| Home > Faculties & Divisions > Cardiac & Vascular Sciences > Academic Vascular Surgery Research Unit | ||
Academic Vascular Surgery Research UnitResearch purpose: The academic vascular surgery research unit (AVSRU) was established in 2003 to investigate the aetiology of degenerative vascular diseases.The overall aim of our research is to identify new therapeutic targets for stabilisation of atherosclerotic plaques and aortic aneurysms.Whilst development of atherosclerotic plaques and aortic aneurysms share a number of common processes eg., inflammation, thrombosis, angiogenesis, and apoptosis, they are strikingly different in that whilst atherosclerotic plaques can naturally stabilise, remaining clinically silent indefinitely, the ultimate fate of the aneurysm is to rupture. Research Strategy: Observations from analysis of proteins, messanger RNAs and specific cells, of human tissues sampled from consenting patients have defined hypotheses which we are testing at the pre-clinical level.Hypotheses which are borne out in pre-clinical testing will be translated to clinical trials were practically possible.Currently we have two clinical strategies under investigations: [1] The ability of reconstituted High-density lipoprotein (rHDL) particles to promote plaque stability in patients undergoing carotid endarterectomy — we are measuring the ability of a short infusion of rHDLs to alter the expression profile of the plaque from an unstable to a stable phenotype. [2] The use of thiazolidenediones (TZD) to stabilise abdominal aortic aneurysms — patients with small aneurysm will be prescribed either TZD or placebo and the rate of growth of the aneurysm measured using ultrasound over a period of two years. Research Facilities:. (i) Exclusive facilities:
(ii) Core facilities:
(iii) Collaborative facilities:
Clinical Infrastructure of Aneurysm Research: Professor Matt Thompson, Professor of Vascular Surgery at St George’s Hospital NHS Trust and Clinical Lead of AVSRU, has the largest aneurysm practice in the UK, and has 8 consultants.The Vascular Unit will be commencing a screening programme for males over 65 year in the future, and these patients, and age matched controls will be recruited into proposed research projects. The Clinical Trials Unit, administered through the Vascular Unit, provides a dedicated unit, with its own infrastructure for introducing translational research into clinical practice. The Trials Unit has over a decade of experience in running multi-centre clinical trials. Research Funding: Equipment:Most equipment, with the exception of the -80oC freezers, and the invert-phase fluorescence microscope, was purchased through a ‘laboratory start-up’ grant awarded to Dr Cockerill by the Garfield Weston Foundation.The freezers and fluorescent microscope (which is a communal facility) was funded through the St George’s Charitable Foundation Equipment Users Committee.Blood pressure monitoring equipment was purchased thorough an award made by the FH Muirhead Charitable Trust. Research salaries and consumables: Research consumables and staff salaries have been funded through awards from the British Heart Foundation, Wellcome Trust, British Cardiac Society, National Heart Foundation, Royal College of Surgeons as well as Industry (Medtronics, Pfizer, Merck Sharp and Dohme and Cooke). |
SCIENTIFIC LEAD: Dr Gillian W Cockerill
CLINICAL LEAD: Professor Mathew M Thompson |
|